Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis
How to Cite
OrthoEvidence. Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis. ACE Report. 2021;22(1):1. Available from: https://myorthoevidene.com/AceReport/Report/13444
Comparison of Botulinum Toxin A, Corticosteroid, and Anesthetic Injection for Plantar FasciitisFoot Ankle Int. 2021 Mar;42(3): 305-313.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Seventy-one patients with ≥2 months of persisting heel pain at the origin of the plantar fascia unresponsive to conventional therapies were randomized to receive a single injection of ropivacaine (5 mL; n=23), an intra-lesional injection of betamethasone sodium phosphate (1 mL; n=25), or an intralesional injection of 200 U of botulinum toxin A (BoNT-A; n=23) injection, administered using ultrasoun...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE